Cargando…
Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction
SIMPLE SUMMARY: Renal cell carcinoma (RCC) is the eighth leading malignancy in the world, accounting for 4% of all cancers with poor outcome when metastatic. Protein kinases are highly druggable proteins, which are often aberrantly activated in cancers. The aim of our study was to identify candidate...
Autores principales: | Giacosa, Sofia, Pillet, Catherine, Séraudie, Irinka, Guyon, Laurent, Wallez, Yann, Roelants, Caroline, Battail, Christophe, Evrard, Bertrand, Chalmel, Frédéric, Barette, Caroline, Soleilhac, Emmanuelle, Fauvarque, Marie-Odile, Franquet, Quentin, Sarrazin, Clément, Peilleron, Nicolas, Fiard, Gaëlle, Long, Jean-Alexandre, Descotes, Jean-Luc, Cochet, Claude, Filhol, Odile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867364/ https://www.ncbi.nlm.nih.gov/pubmed/33540838 http://dx.doi.org/10.3390/cancers13030576 |
Ejemplares similares
-
Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma
por: Roelants, Caroline, et al.
Publicado: (2020) -
A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell Carcinoma
por: Séraudie, Irinka, et al.
Publicado: (2023) -
COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage
por: Koca, Dzenis, et al.
Publicado: (2023) -
Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma
por: Roelants, Caroline, et al.
Publicado: (2018) -
Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma
por: Caroline, Roelants, et al.
Publicado: (2019)